# Gary Glausser

> Gary Glausser is a Series A investor at Birchmere Ventures backing Health Care. See 4 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Fund: [Birchmere Ventures](https://shizune.co/investors/profile/birchmere-ventures)
- Location: Pittsburgh, United States
- Total investments: 4
- Last investment: Sep 2013
- Lead investor: 25%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/gary-g-glausser-172a253

Gary Glausser is a Series A investor at Birchmere Ventures in Pittsburgh focused on Health Care and Medical Device. Gary Glausser is the Managing Director at Riverfront Ventures.

## Contacts

5 contacts available for Gary Glausser: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/gary-glausser?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 50% |
| Medical Device | 2 | 50% |
| Medical | 1 | 25% |
| Therapeutics | 1 | 25% |
| Biotechnology | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Series B | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ALung Technologies | ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placedwithin the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein.The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania. | $15.8M | Series B | Sep 11, 2013 | http://www.alung.com |
| ALung Technologies | ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placedwithin the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein.The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania. | $10M | Series B | Feb 06, 2012 | http://www.alung.com |
| ALung Technologies | ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placedwithin the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein.The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania. | $14M | Series A | Oct 11, 2010 | http://www.alung.com |
| Renal Solutions | Renal Solutions is focused on the development of dialysis products and services. Renal Solutions was acquired by Fresenius Medical Care in November 2007. Renal Solutions was founded in 2000 and is based in Warrendale, Pennsylvania. | $14.7M | Series A | Dec 03, 2002 | http://www.renalsolutionsinc.com/ |

4 of 4 investments shown.

## Co-investors
- Eagle Ventures — VC Fund, 3 deals together
- MAG Ventures — VC Fund, 2 deals together
- [Accelerator Fund](https://shizune.co/investors/profile/accelerator-fund) — VC Fund, 1 deal together
- [Allos Ventures](https://shizune.co/investors/profile/allos-ventures) — VC Fund, 1 deal together
- Amkey Ventures — VC Fund, 1 deal together
- [Blue Chip Venture Company](https://shizune.co/investors/profile/blue-chip-venture-company) — VC Fund, 1 deal together

## About Birchmere Ventures

VC Fund · Pittsburgh, United States

Across five funds and two decades, we've helped build numerous successful companies such as Cvent (event management - IPO) , TenMarks (math tutoring - acquired by Amazon) CyOptics (optical chips - acquired by Avago), Neolinear (EDA - acquired by Cadence), and FreeMarkets (B2B marketplace - IPO).We believe great companies can start anywhere(but to scale quickly they may require a coastal presence), and the best engineers and scientists do not go to just a few schools on each coast. These core principles lead us to invest in companies from across the country overlooked by many other investors, uncovering hidden gems and helping them scale up.

4 contacts available at Birchmere Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Ned Renzi | Fouding Partner | https://shizune.co/investors/profile/ned-renzi |
| Sean Sebastian | Partner | https://shizune.co/investors/profile/sen-sebastian |
| Ivan Koon | Venture Partner | https://shizune.co/investors/profile/ivan-koon |
| Sean Ammirati | Partner | https://shizune.co/investors/profile/sean-ammirati |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Gary Glausser invest in?

Gary Glausser invests primarily in Health Care, Medical Device and Medical startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Gary Glausser?

Public channels for Gary Glausser include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Gary Glausser last invest?

The most recent investment recorded for Gary Glausser closed in Sep 2013. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co